Phialogics is an innovative start-up in the field of autoimmune diseases. Founded in 2021 by a team of widely recognized experts in protein engineering and immunology, the company based in Basel (CH) and Heidelberg (GER) is committed to making a decisive contribution to the autoimmune disease space. The founding team is backed by strong Scientific Advisory and Supervisory Boards, which puts the company in a good position to move fast on the lead candidate and develop novel biologics.
Location: Germany, Hesse, Frankfurt
Employees: 1-10
Total raised: $661.5K
Investors 1
| Date | Name | Website |
| - | High-Tech ... | htgf.de |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.05.2023 | Pre-Seed | $661.5K | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 05.05.2023 | Phialogics Raises €600K in Pre-Seed Financing | Phialogics, a Basel, Switzerland and Heidelberg, Germany-based startup which specializes in the fiel... | finsmes.co... |
| 19.04.2023 | Phialogics secures pre-seed financing for Next-Gen IgV Thera... | April 19, 2023 Basel, 19 April 2023 – Being able to rebalance the immune response in acute and chro... | htgf.de/en... |
| 19.04.2023 | Phialogics closes 600,000 € pre-seed financing round | Being able to rebalance the immune response in acute and chronic inflammation is key for many pati... | startuptic... |
| - | Phialogics | “Home” | fastfounde... |